What Is HDL Cholesterol? Normal vs Optimal Range Explained

The lab reference range marks HDL below 40 mg/dL as "low" and above 60 mg/dL as "desirable," but treating any HDL above 40 as adequate grossly underestimates cardiovascular risk. HDL particles perform reverse cholesterol transport—extracting cholesterol from atherosclerotic plaques and delivering it to the liver for excretion. The CTD documents over 7,600 compound interactions with HDL metabolism pathways, reflecting the extensive pharmacological and dietary influence on HDL levels and function. The optimal range of 55–90 mg/dL represents the zone where reverse cholesterol transport operates with protective efficiency. HDL between 40 and 55 in men (or 40–65 in women) falls in a risk zone where plaque removal capacity is suboptimal but labs won't flag a problem. The triglyceride-to-HDL ratio is an especially powerful metric: a ratio below 2.0 indicates good insulin sensitivity, while above 3.5 strongly predicts insulin resistance and cardiovascular risk.

PubMed indexes over 92,000 publications on HDL cholesterol, and the understanding of HDL has evolved significantly beyond simple concentration measurement. HDL particle function—specifically cholesterol efflux capacity (how effectively HDL removes cholesterol from macrophages in artery walls)—may matter more than HDL level alone. This explains the paradoxical finding that pharmaceutical HDL elevation with CETP inhibitors (torcetrapib, dalcetrapib) failed to reduce cardiovascular events despite raising HDL numbers. The raised HDL particles weren't functionally protective. In clinical practice, natural HDL elevation through exercise, weight loss, moderate alcohol consumption, and omega-3 fatty acids tends to produce functionally superior HDL particles compared to pharmacological HDL elevation, which explains the consistent cardiovascular benefit of lifestyle-driven HDL improvement.

FAERS documents over 45,000 adverse event reports involving lipid panel abnormalities, and low HDL is the most common lipid abnormality associated with metabolic syndrome—a cluster that includes elevated triglycerides, elevated fasting glucose, abdominal obesity, and hypertension. Low HDL rarely occurs in isolation; it's typically part of a metabolic pattern driven by insulin resistance. Visceral adiposity and insulin resistance increase hepatic lipase activity, which breaks down HDL particles and reduces their circulating concentration. Addressing insulin resistance—through dietary modification, exercise, and weight loss—simultaneously raises HDL, lowers triglycerides, improves fasting glucose, and reduces blood pressure, demonstrating that these aren't independent risk factors but manifestations of a single underlying metabolic dysfunction.